Plain-English translation of NCT07149792 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Psoriasis research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
Researchers are testing a new approach to treating psoriasis and psoriatic arthritis using biologic medications like adalimumab, golimumab, and secukinumab. Instead of giving patients one of these medications and hoping it works, the study tests whether doctors can predict which medication will be most effective by examining how each patient's immune cells respond to different drugs in the lab. The goal is to help patients get the right treatment faster and more reliably.
Many patients with psoriasis and psoriatic arthritis have to try multiple medications before finding one that works, which wastes time and delays relief from pain and symptoms. This study explores whether personalized testing of a patient's immune response can predict which medication will work best upfront, potentially helping patients avoid unnecessary treatments and get better results sooner.
You likely qualify if…
You likely don't qualify if…
You will visit the study center to have about 16 milliliters of blood drawn (roughly 3 teaspoons). Researchers will then grow your immune cells in the laboratory and expose them to different biologic medications to see which ones work best against your condition. You may be assigned to either receive a standard medication recommended by current treatment guidelines, or to receive a medication chosen based on how your specific immune cells responded to it in the lab testing. The study will track your response to the medication and also monitor markers that predict heart health.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Taiwan